Project description
A nanoparticle platform for tumour profiling
Recent years have witnessed a significant increase in the use of nanomaterials for cancer theranostics. However, the physiological barriers of the tumour microenvironment (TME) alongside tumour heterogeneity pose major limitations to treatment and therapy. Scientists of the EU-funded GelGeneCircuit project propose to investigate how tumours respond to therapy as well as the underlying factors for the observed heterogeneity. To achieve this, they will develop a hydrogel-based platform for the delivery of nanoparticles that will assist in tumour profiling. Using this approach, they aim to identify novel biological targets and dissect key molecular mechanisms that will prove useful for the design of effective anti-cancer strategies.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
ERC-STG - Starting GrantHost institution
1099 085 Lisboa
Portugal
See on map
Beneficiaries (2)
1099 085 Lisboa
See on map
Participation ended
1649 028 Lisboa
See on map